Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Supreme Court
Supreme Court
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Tue, 01/24/23 - 06:18 pm
Novartis
Supreme Court
Gilenya
patents
generics
multiple sclerosis
MS
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
Reuters
Tue, 01/10/23 - 10:59 am
Pfizer
Supreme Court
Medicare
kickbacks
Vyndaqel
Vyndamax
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Amgen
Sanofi
Regeneron
Supreme Court
legal
innovation
patents
Repatha
Praluent
Pfizer's Supreme Court challenge of US kickback law is 'far-fetched,' HHS says
Fierce Pharma
Thu, 12/15/22 - 11:21 pm
Pfizer
legal
kickbacks
Supreme Court
rebates
Medicare
A Supreme Court chill across biosimilar 'skinny' labels could halt billions in Medicare savings
Endpoints
Tue, 11/29/22 - 08:26 pm
Medicare
skinny labels
biosimilars
Supreme Court
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court
Fierce Pharma
Tue, 11/15/22 - 10:32 am
Pfizer
JNJ
copay asssistance programs
kickbacks
Vyndaqel
Vyndamax
Supreme Court
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Mon, 10/17/22 - 11:31 pm
Pfizer
Supreme Court
kickbakcs
tafamidis
copays
Vyndaqel
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
In 'skinny' label fight between Teva and GSK, Supreme Court asks Biden admin for help
Fierce Pharma
Tue, 10/4/22 - 11:01 am
GSK
Teva Pharmaceutical
Joe Biden
Supreme Court
skinny labels
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Facing 'imminent' Gilenya generics and a $300M sales hit, Novartis takes patent fight to Supreme Court
Fierce Pharma
Wed, 09/21/22 - 08:02 pm
Novartis
Supreme Court
Gilenya
patents
legal
MS
Teva fires back at GSK again over potential 'skinny' label SCOTUS case
Endpoints
Thu, 09/8/22 - 04:43 pm
Teva Pharmaceutical
GSK
skinny labels
Supreme Court
legal
Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud
Fierce Pharma
Sun, 08/28/22 - 10:19 pm
Gilead Sciences
CAR-T
patents
Supreme Court
Kite Pharma
Bristol Myers Squibb
Eli Lilly says Indiana's abortion ban will force it to hire more outside the state
Fierce Pharma
Mon, 08/8/22 - 10:08 am
Eli Lilly
Indiana
abortion
Supreme Court
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Endpoints
Tue, 07/19/22 - 10:01 pm
Amgen
GSK
Regenxbio
Supreme Court
innovation
patents
Teva warns 'skinny label' ruling could sow 'competition-killing uncertainty' for generics
Fierce Pharma
Thu, 07/14/22 - 11:47 am
Teva Pharmaceutical
Supreme Court
skinny labels
GSK
patents
Biogen gains prominent ally in bid for Supreme Court to review Tecfidera patent case
Fierce Pharma
Wed, 07/13/22 - 08:17 pm
Biogen
Tecfidera
patents
Supreme Court
Supreme Court Decision On EPA Could Have Implications For Other Regulatory Agencies, Like FDA
Forbes
Tue, 07/5/22 - 11:49 am
regulatory
Supreme Court
FDA
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »